Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12618839 | Antibodies for detecting Epstein Barr virus-positive gastric cancer | 🖼🧊📄§ | 2026-05-05 | 2040-10-23 | 0 | 31 |
| 12617863 | Humanized anti-glycoprotein Ib alpha (GPIbalpha) antibodies | 🖼🧊📄§ | 2026-05-05 | 2040-12-10 | 0 | 31 |
| 12617860 | Anti-TNFR2 antibody and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-01-05 | 0 | 31 |
| 12617868 | Activation of (Na++K+)-ATPase inhibits platelet aggregation and prevents thrombosis | 🖼🧊📄§ | 2026-05-05 | 2042-11-08 | 0 | 31 |
| 12620468 | Personalized liver cancer treatment | 🖼🧊📄§ | 2026-05-05 | 2045-03-06 | 0 | 31 |
| 12616742 | Recombinant heme oxygenase-1 (HO-1) for the treatment of sickle cell disease | 🖼🧊📄§ | 2026-05-05 | 2040-07-24 | 0 | 31 |
| 12617755 | Compositions and methods for treating metabolic disease | 🖼🧊📄§ | 2026-05-05 | 2040-08-03 | 0 | 31 |
| 12616672 | Methods for assessing risk of cardiovascular disease and methods and compounds for use in treating or preventing cardiovascular disease | 🖼🧊📄§ | 2026-05-05 | 2038-09-19 | 0 | 31 |
| 12616680 | Combined use of biotin and thiamine in the treatment of huntington's disease | 🖼🧊📄§ | 2026-05-05 | 2040-09-23 | 0 | 31 |
| 12616688 | Cell glycocalyx protection effect of anisodamine | 🖼🧊📄§ | 2026-05-05 | 2041-09-01 | 0 | 31 |
| 12616695 | Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of rare chronic inflammatory pulmonary diseases | 🖼🧊📄§ | 2026-05-05 | 2041-01-29 | 0 | 31 |
| 12616730 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-03-10 | 0 | 31 |
| 12616602 | Bacteria formulation and products including same | 🖼🧊📄§ | 2026-05-05 | 2041-08-04 | 0 | 31 |
| 12616702 | Use of reboxetine to treat narcolepsy | 🖼🧊📄§ | 2026-05-05 | 2044-08-29 | 0 | 31 |
| 12616673 | Compounds for use in the treatment of leukemia | 🖼🧊📄§ | 2026-05-05 | 2041-01-28 | 0 | 31 |
| 12616713 | Methods for enhancing vascular density | 🖼🧊📄§ | 2026-05-05 | 2043-01-20 | 0 | 31 |
| 12616703 | Methods of contraception using nomegestrol acetate and estradiol | 🖼🧊📄§ | 2026-05-05 | 2041-10-12 | 0 | 31 |
| 12616674 | Anti-fibrotic NEU3 inhibitor compounds and methods of use | 🖼🧊📄§ | 2026-05-05 | 2040-02-10 | 0 | 31 |
| 12616667 | Compositions and methods for improving neurological diseases and disorders | 🖼🧊📄§ | 2026-05-05 | 2042-11-14 | 0 | 31 |
| 12617782 | Pyridazinones as PARP7 inhibitors | 🖼🧊📄§ | 2026-05-05 | 2043-05-12 | 0 | 31 |
| 12618072 | Methods of treatment of SCN2A-related disorders | 🖼🧊📄§ | 2026-05-05 | 2044-09-13 | 0 | 31 |
| 12617825 | Methods and compositions for reducing the immunogenicity of chimeric notch receptors | 🖼🧊📄§ | 2026-05-05 | 2042-04-08 | 0 | 31 |
| 12617858 | Anti-Müllerian hormone receptor 2 antibodies and methods of use | 🖼🧊📄§ | 2026-05-05 | 2041-01-29 | 0 | 31 |
| 12617861 | Anti-OX40 antibody and method of treatment | 🖼🧊📄§ | 2026-05-05 | 2041-04-16 | 0 | 31 |
| 12616662 | Lipid particles for nucleic acid delivery and clinical applications of same | 🖼🧊📄§ | 2026-05-05 | 2042-11-17 | 0 | 31 |
| 12617809 | Cardioprotective lipid and method of use | 🖼🧊📄§ | 2026-05-05 | 2042-09-22 | 0 | 31 |
| 12616656 | Adventitial painting modality of local drug delivery to abate intimal hyperplasia | 🖼🧊📄§ | 2026-05-05 | 2042-05-20 | 0 | 31 |
| 12616734 | Chimeric antigen receptor specifically binding to cd 300C antigen or receptor thereof | 🖼🧊📄§ | 2026-05-05 | 2042-05-27 | 0 | 31 |
| 12616666 | Coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa | 🖼🧊📄§ | 2026-05-05 | 2042-07-13 | 0 | 31 |
| 12616669 | Methods and chemical compositions for treating skin conditions by providing long lasting skin pH control for improving skin barrier function | 🖼🧊📄§ | 2026-05-05 | 2045-08-27 | 0 | 31 |
| 12616657 | Cell-targeted nanoparticles to inhibit RNA cargo | 🖼🧊📄§ | 2026-05-05 | 2041-02-26 | 0 | 31 |
| 12616747 | Stabilized beta-coronavirus antigens | 🖼🧊📄§ | 2026-05-05 | 2042-12-02 | 0 | 31 |
| 12616727 | Compositions, systems, and methods for improving health | 🖼🧊📄§ | 2026-05-05 | 2043-06-29 | 0 | 31 |
| 12616712 | Sting agonist comprising exosomes for treating neuroimmunological disorders | 🖼🧊📄§ | 2026-05-05 | 2040-09-24 | 0 | 31 |
| 12616692 | Method of achieving HIV viral remission using long-acting antiretroviral agents | 🖼🧊📄§ | 2026-05-05 | 2041-06-30 | 0 | 31 |
| 12616671 | Use of rigosertib to treat RNA virus infections | 🖼🧊📄§ | 2026-05-05 | 2041-05-28 | 0 | 31 |
| 12617813 | Glycosylated histone deacetylase inhibitors and methods of making and using the same | 🖼🧊📄§ | 2026-05-05 | 2041-12-28 | 0 | 31 |
| 12618031 | Delivery devices | 🖼🧊📄§ | 2026-05-05 | 2041-06-24 | 0 | 31 |
| 12616761 | CXCR4-targeting compounds | 🖼🧊📄§ | 2026-05-05 | 2044-06-27 | 0 | 31 |
| 12616684 | Pulmonary fibrosis medicine containing pyrazole derivative | 🖼🧊📄§ | 2026-05-05 | 2041-03-23 | 0 | 31 |
| 12616705 | Use of cannabinoids in the treatment of Angelman syndrome | 🖼🧊📄§ | 2026-05-05 | 2043-05-02 | 0 | 31 |
| 12616706 | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations | 🖼🧊📄§ | 2026-05-05 | 2040-03-06 | 0 | 31 |
| 12616741 | Therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD | 🖼🧊📄§ | 2026-05-05 | 2041-03-17 | 0 | 31 |
| 12617823 | Broad-spectrum peptide antigen of the novel coronavirus SARS-COV-2, specific neutralizing antibody and use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-07-21 | 0 | 31 |
| 12616681 | Compositions and methods for treating renal injury | 🖼🧊📄§ | 2026-05-05 | 2042-08-22 | 0 | 31 |
| 12616677 | Injectable pharmaceutical compositions and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2040-05-01 | 0 | 31 |
| 12616678 | Methods to of aldehyde dehydrogenases for treatment of cancer | 🖼🧊📄§ | 2026-05-05 | 2041-06-10 | 0 | 31 |
| 12616689 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | 🖼🧊📄§ | 2026-05-05 | 2043-08-30 | 0 | 31 |
| 12616690 | Specific AKT3 activator and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2044-03-15 | 0 | 31 |
| 12616687 | Treatment of viral infection, disease or disorder using a selective sir agonist | 🖼🧊📄§ | 2026-05-05 | 2042-11-04 | 0 | 31 |